Failure of anti-TNF therapy in TNF receptor 1-Associated periodic syndrome (TRAPS)

[1] Etanercept plus colchicine treatment in a child with tumour necrosis factor receptor-associated periodic syndrome abolishes auto-inflammatory episodes without normalising the subclinical acute phase response [J]. EUROPEAN JOURNAL OF PEDIATRICS, 2005, 164 (01) : 13 - 16

[2] Dodé C, 2000, ARTHRITIS RHEUM-US, V43, P1535, DOI 10.1002/1529-0131(200007)43:7<1535::AID-ANR18>3.0.CO

[3] 2-C

[4] Emerging clinical spectrum of tumor necrosis factor receptor-associated periodic syndrome: comment on the articles by Hull et al and Dode et al [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (06): : 1768 - 1769

[5] Prospective study of anti-tumour necrosis factor receptor superfamily 1B fusion protein, and case study of anti-tumour necrosis factor receptor superfamily 1A fusion protein, in tumour necrosis factor receptor associated periodic syndrome (TRAPS): clinical and laboratory findings in a series of seven patients [J]. RHEUMATOLOGY, 2003, 42 (02) : 235 - 239

[6] Drewe E, 2002, CLIN EXP RHEUMATOL, V4, pS71

[7] TNF-receptor associated periodic syndrome (TRAPS): clinical and immunopathologic characteristics of a rare hereditary periodic fever syndrome [J]. ARCHIVES DE PEDIATRIE, 2003, 10 (01): : 45 - 53

[8] Hull KM, 2002, ARTHRITIS RHEUM-US, V46, pS378

[9] Systemic cytokine levels and the effects of etanercept in TNF receptor-associated periodic syndrome (TRAPS) involving a C33Y mutation in TNFRSF1A [J]. RHEUMATOLOGY, 2006, 45 (01) : 31 - 37

[10] Infevers: An evolving mutation database for auto-inflammatory syndromes [J]. HUMAN MUTATION, 2004, 24 (03) : 194 - 198

[1] Etanercept plus colchicine treatment in a child with tumour necrosis factor receptor-associated periodic syndrome abolishes auto-inflammatory episodes without normalising the subclinical acute phase response [J]. EUROPEAN JOURNAL OF PEDIATRICS, 2005, 164 (01) : 13 - 16

[2] Dodé C, 2000, ARTHRITIS RHEUM-US, V43, P1535, DOI 10.1002/1529-0131(200007)43:7<1535::AID-ANR18>3.0.CO

[3] 2-C

[4] Emerging clinical spectrum of tumor necrosis factor receptor-associated periodic syndrome: comment on the articles by Hull et al and Dode et al [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (06): : 1768 - 1769

[5] Prospective study of anti-tumour necrosis factor receptor superfamily 1B fusion protein, and case study of anti-tumour necrosis factor receptor superfamily 1A fusion protein, in tumour necrosis factor receptor associated periodic syndrome (TRAPS): clinical and laboratory findings in a series of seven patients [J]. RHEUMATOLOGY, 2003, 42 (02) : 235 - 239

[6] Drewe E, 2002, CLIN EXP RHEUMATOL, V4, pS71

[7] TNF-receptor associated periodic syndrome (TRAPS): clinical and immunopathologic characteristics of a rare hereditary periodic fever syndrome [J]. ARCHIVES DE PEDIATRIE, 2003, 10 (01): : 45 - 53

[8] Hull KM, 2002, ARTHRITIS RHEUM-US, V46, pS378

[9] Systemic cytokine levels and the effects of etanercept in TNF receptor-associated periodic syndrome (TRAPS) involving a C33Y mutation in TNFRSF1A [J]. RHEUMATOLOGY, 2006, 45 (01) : 31 - 37

[10] Infevers: An evolving mutation database for auto-inflammatory syndromes [J]. HUMAN MUTATION, 2004, 24 (03) : 194 - 198